Physician profile
Niraj Bhalakia
NPI 1841426558
$2,722.71
in general payments reported to CMS, 2019-2025
7 companies · $936 in 2025
The $936 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,470 · 2024: $317 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,518 · Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,517.52 |
| Food and Beverage | $1,205.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,094.48 | 2023 | Augment Injectable, Spinejack |
| Penumbra, INC. | $1,011.94 | 2024-2025 | Ruby Coil |
| Inari Medical, INC. | $207.47 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ethicon INC. | $130.76 | 2023 | Monarch Platform |
| Medtronic, INC. | $123.20 | 2023 | Emprint |
| W. L. Gore & Associates, INC. | $121.32 | 2023 | Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Bard Peripheral Vascular, INC. | $33.54 | 2025 | Denali Vena Cava Filter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Bhalakia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.